184 related articles for article (PubMed ID: 16423058)
1. High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.
Jimenez-Flores R; Mendez-Cruz R; Ojeda-Ortiz J; Muñoz-Molina R; Balderas-Carrillo O; de la Luz Diaz-Soberanes M; Lebecque S; Saeland S; Daneri-Navarro A; Garcia-Carranca A; Ullrich SE; Flores-Romo L
Immunology; 2006 Feb; 117(2):220-8. PubMed ID: 16423058
[TBL] [Abstract][Full Text] [Related]
2. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
3. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection.
Gonçalves MA; Soares EG; Fernandes AP; Fonseca BA; Bettini JS; Simões RT; Donadi EA
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):221-7. PubMed ID: 15140519
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
Jain BB; Adhikary T; Sadhukhan PC; Nandi A
J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
[TBL] [Abstract][Full Text] [Related]
5. Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia.
Shepherd PS; Rowe AJ; Cridland JC; Coletart T; Wilson P; Luxton JC
J Gen Virol; 1996 Apr; 77 ( Pt 4)():593-602. PubMed ID: 8627247
[TBL] [Abstract][Full Text] [Related]
6. The expression of histocompatibility antigen HLA-DR in cervical squamous epithelium infected with human papilloma virus.
Warhol MJ; Gee B
Mod Pathol; 1989 Mar; 2(2):101-4. PubMed ID: 2542929
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
8. Langerhans cell density in cervical intraepithelial neoplasia associated with human papillomavirus infection in HIV-infected and HIV-noninfected Brazilian women.
Zimmermmann JB; Gobbi H; Alves MJ; Quirino MG; Melo VH
Int J Gynecol Cancer; 2012 Oct; 22(8):1291-6. PubMed ID: 22932260
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
[TBL] [Abstract][Full Text] [Related]
10. Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia.
van Seters M; Beckmann I; Heijmans-Antonissen C; van Beurden M; Ewing PC; Zijlstra FJ; Helmerhorst TJ; KleinJan A
Cancer Res; 2008 Aug; 68(16):6617-22. PubMed ID: 18701485
[TBL] [Abstract][Full Text] [Related]
11. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix.
Seresini S; Origoni M; Caputo L; Lillo F; Longhi R; Vantini S; Paganoni AM; Protti MP
Immunology; 2010 Sep; 131(1):89-98. PubMed ID: 20545782
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.
Shah KV; Viscidi RP; Alberg AJ; Helzlsouer KJ; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):233-7. PubMed ID: 9107427
[TBL] [Abstract][Full Text] [Related]
15. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
Hughes RG; Norval M; Howie SE
J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
[TBL] [Abstract][Full Text] [Related]
16. Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle.
Aggarwal R; Sharma M; Mangat N; Suri V; Bhatia T; Kumar P; Minz R
J Reprod Immunol; 2020 Nov; 142():103205. PubMed ID: 33099242
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
18. Flow Cytometry Characterization of Pluripotent Transmembrane Glycoproteins on Resident Cervix Uteri Cells in Patients Screened for Cervical Cancer.
Colacurci N; Schettino MT; Grimaldi V; De Luca FP; Mansueto G; Costa D; Cacciatore F; De Franciscis P; Napoli C
Cancer Invest; 2020 Apr; 38(4):228-239. PubMed ID: 32208057
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]